Reading this on a mobile device? Try our optimized mobile version here:

March 7, 2013News for medical technology professionals

  Top Story 
  • Medtronic obtains approval for cardiac leads in Europe
    Medtronic has received the green light in Europe for its Attain Performa line of quadripolar leads, which are used with the company's Viva/Brava cardiac resynchronization therapy defibrillators. The devices are equipped with features that aid doctors in providing personalized care to heart failure patients, a company official said. (Boston) (3/6) LinkedInFacebookTwitterEmail this Story
 Free On-Demand Webinar: Pilgrim Training Management Product Showcase
Processes, regulations and documentation changes drive constant challenges in employee training and knowledge management. Discover how to increase organizational control and enforce SOPs through automated document and training management. DOWNLOAD THIS FREE WEBINAR NOW.

  Business & Market Trends 
  • MxBiodevices seeks $8 million for diabetic foot ulcer study
    MxBiodevices is hoping to raise $8 million to support a pivotal trial of its E-Matrix bioscaffold, which is intended to help treat wounds in patients with diabetic foot ulcers. The Greenville, N.C.-based company will use the trial to back its FDA premarket approval application for the device, which already has 510(k) clearance for spine and orthopedic uses. (3/6) LinkedInFacebookTwitterEmail this Story
  • CEO of Stereotaxis leaves post
    Michael Kaminski is resigning as president and CEO of Stereotaxis, effective on April 12. The company's board has tapped Chairman William Mills III to serve as CEO on an interim basis and has enlisted Director Euan Thomson to help with the transition to new leadership. RTT News (3/5) LinkedInFacebookTwitterEmail this Story
  International Developments 
  • Mobile oncology application from ONCOassist gets CE mark
    ONCOassist has received the CE mark in Europe for a smartphone application designed to give oncologists mobile access to point-of-care clinical decision support tools. The ONCOassist app was designed for the iPad and iPhone, but the Irish company plans to have the technology available for Android devices in six to 12 months. Silicon Republic (Ireland) (3/6) LinkedInFacebookTwitterEmail this Story
  Industry Insight 

  Science & Health 
  • Method could prevent GVHD in bone marrow transplants
    Blocking the Notch signaling pathway in donor cells may reduce the risk of graft-versus-host disease after bone marrow transplants, a University of Michigan team reports in the Journal of Clinical Investigation. Targeting a ligand-receptor pair in the Notch signaling pathway prevented the disease in mice and did not cause adverse effects or affect the ability of the transplanted cells to fight cancer, according to the study. The findings open new routes for possible treatments of T cell-related conditions in transplants, an investigator said. Genetic Engineering & Biotechnology News (3/1) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
  Government & Regulatory 
AdvaMed News 
  • Design and Analysis Challenges for Pediatrics and Rare Diseases
    Monday, April 22
    Sheraton Crystal City, Arlington, Va.
    This meeting gives viewpoints from various stakeholders -- physicians, regulators, ethicists, payers, patients, statisticians and  clinical researchers -- and shows you how to provide medical devices and diagnostics to pediatric and rare disease populations that are supported by data from appropriately designed and analyzed clinical trials. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
  • 6th Annual FDA/MTLI Medical Devices and IVD Statistical Issues Workshop
    Tuesday, April 23 – Wednesday, April 24
    Sheraton Crystal City, Arlington, Va.
    This annual conference, co-sponsored by the FDA and AdvaMed, brings together leading authorities from the FDA, industry and academia to address statistical topics such as CDISC, data standard, FDA guidances, sample size estimation and re-estimation, and more. On Day 2, the conference will be split into focus areas: therapeutic devices and IVD products addressing guidance documents; a report from the equivocal results sub-group; combination products; and technology-related issues. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

Position TitleCompany NameLocation
Sales Area Manager/Sales Rep of Neurovascular Intervention ProductsAsahi Intecc USA, Inc.Any location in US, CA
Compliance Consultant 2DJO GlobalVista, CA
Accreditation ManagerAmerican Association of Tissue BanksMcLean, VA
Director, Health Care ComplianceRTI BiologicsAlachua, FL
Director of Global Infrastructure - 002196Edwards LifesciencesIrvine, CA
Manager, HCL Regulatory & Quality ComplianceOwens & MinorLouisville, KY
DIR OPERATIONS, Milpitas Site - 130000007RAbbott San Jose, CA
Engineer, Process DevelopmentArthroCare CorporationIrvine, CA
Biostatistician - Post Market Surveillance Johnson & JohnsonRaynham, MA
Click here to view more job listings.

Scientific progress makes moral progress a necessity; for if man's power is increased, the checks that restrain him from abusing it must be strengthened."
--Anne Louise Germaine de Staël,
Swiss author

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
A powerful website for SmartBrief readers including:
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information